61
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prevalence, clinical characteristics and treatment outcomes of oxyntic gland neoplasm: a single-center retrospective study

, , , , , & show all
Pages 524-532 | Received 03 Nov 2023, Accepted 21 Jan 2024, Published online: 31 Jan 2024

References

  • Tsukamoto T, Yokoi T, Maruta S, et al. Gastric adenocarcinoma with chief cell diferentiation. Pathol Int. 2007;57(8):517–522. doi: 10.1111/j.1440-1827.2007.02134.x.
  • Ueyama H, Yao T, Nakashima Y, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010;34(5):609–619. doi: 10.1097/PAS.0b013e3181d94d53.
  • Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 15th ed. Tokyo: Kanehara Shuppan; 2017.
  • Yao T, Vieth M, Carneiro F, et al. Tumours of the stomach. Oxyntic gland adenoma and gastric adenocarcinoma of fundic-gland type. In D Lokuhetty, VA White, R Watanabe eds. World health organization classification of digestive system tumours, 5th edn. Lyon: IARC Press, 2019;83–92.
  • Asahara H, Takao T, Asahara Y, et al. Clinicopathological features and the prevalence of oxyntic gland neoplasm: a single-center retrospective study. Intern Med. 2023;62(19):2763–2774. doi: 10.2169/internalmedicine.0552-22.
  • Ueyama H, Yao T, Akazawa Y, et al. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classfication in association with gastric adenocarcinoma of fundic-gland type. J Gastroenterol. 2021;56(9):814–828. doi: 10.1007/s00535-021-01813-z.
  • Lee TI, Jang JY, Kim S, et al. Oxyntic gland adenoma endoscopically mimicking a gastric neuroendocrine tumor: a case report. World J Gastroenterol. 2015;21(16):5099–5104. doi: 10.3748/wjg.v21.i16.5099.
  • Lewin E, Daroca P, Sikka S, et al. Gastric adenocarcinoma of the fundic gland type treated by endoscopic mucosal resection: a case report and review of the literature. Case Rep Pathol. 2016;2016:8646927. 8646927. doi: 10.1155/2016/8646927.
  • Zhou C, Chen G, Jiang JG. The gastric oxyntic gland neoplasm: a case series. Asian J Surg. 2022;45(1):598–599. doi: 10.1016/j.asjsur.2021.10.014.
  • Yang M, Sun X, Chen Y, et al. Twenty cases of gastric adenocarcinoma of the fundic gland type. Scand J Gastroenterol. 2023;58(7):744–750. doi: 10.1080/00365521.2022.2164213.
  • Shen FY, Zhuang HJ, Bai DY, et al. Clinicopathological characteristics of 18 cases of oxyntic gland neoplasm from gastric fundic gland. Zhonghua Bing Li Xue Za Zhi. 2023;52(7):718–720.
  • Endoscopic Classification Review Group. Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy. 2005;37(6):570–578. doi: 10.1055/s-2005-861352.
  • Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;41(5):462–467. doi: 10.1055/s-0029-1214594.
  • Cho JH, Shin CM, Yoon H, et al. Comparison of endoscopic treatments for small gastric adenomas. Surg Endosc. 2022;36(6):3920–3931. doi: 10.1007/s00464-021-08710-9.
  • Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1–25. doi: 10.1007/s10120-022-01331-8.
  • Min BH, Lee JH, Kim JJ, et al. Clinical outcomes of endoscopic submucosal dissection (ESD) for treating early gastric cancer: comparison with endoscopic mucosal resection after circumferential precutting (EMR-P). Dig Liver Dis. 2009;41(3):201–209. doi: 10.1016/j.dld.2008.05.006.
  • He MJ, Liu XY, Xu JX, et al. Endoscopic submucosal dissection for gastric adenocarcinoma of the fundic gland type (chief cell predominate type): four years’ experience from a tertiary hospital. J Dig Dis. 2022;23(11):620–627. doi: 10.1111/1751-2980.13149.
  • Tohda G, Osawa T, Asada Y, et al. Gastric adenocarcinoma of fundic gland type: endoscopic and clinicopathological features. World J Gastrointest Endosc. 2016;8(4):244–251. doi: 10.4253/wjge.v8.i4.244.
  • Benedict MA, Lauwers GY, Jain D. Gastric adenocarcinoma of the fundic gland type:  update and literature review. Am J Clin Pathol. 2018;149(6):461–473. doi: 10.1093/ajcp/aqy019.
  • Matsuda A, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2014;44(4):388–396. doi: 10.1093/jjco/hyu003.
  • Miyazawa M, Matsuda M, Yano M, et al. Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): a review of endoscopic and clinicopathological features. World J Gastroenterol. 2016;22(48):10523–10531. doi: 10.3748/wjg.v22.i48.10523.
  • Moss SF. The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 2016;3(2):183–191. doi: 10.1016/j.jcmgh.2016.12.001.
  • Yamamoto Y, Fujisaki J, Omae M, et al. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27(5):551–561. doi: 10.1111/den.12471.
  • Chiba T, Kato K, Masuda T, et al. Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings. Dig Endosc. 2016;28(7):722–730. doi: 10.1111/den.12676.
  • Miyazawa M, Matsuda M, Yano M, et al. Gastric adenocarcinoma of fundic gland type: five cases treated with endoscopic resection. World J Gastroenterol. 2015;21(26):8208–8214. doi: 10.3748/wjg.v21.i26.8208.
  • Fujii M, Uedo N, Ishihara R, et al. Endoscopic features of early stage gastric adenocarcinoma of fundic gland type (chief cell predominant type): a case report. Case Rep Clin Pathol. 2015;2(1):17–22.
  • Iwamuro M, Kusumoto C, Nakagawa M, et al. Endoscopic resection is a suitable initial treatment strategy for oxyntic gland adenoma or gastric adenocarcinoma of the fundic gland type. Sci Rep. 2021;11(1):7375. doi: 10.1038/s41598-021-86893-w.
  • Iwamuro M, Kusumoto C, Nakagawa M, et al. Endoscopic features of oxyntic gland adenoma and gastric adenocarcinoma of the fundic gland type differ between patients with and without Helicobacter pylori infection: a retrospective observational study. BMC Gastroenterol. 2022;22(1):294. doi: 10.1186/s12876-022-02368-w.
  • Kushima R, Sekine S, Matsubara A, et al. Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma. Pathol Int. 2013;63(6):318–325. doi: 10.1111/pin.12070.
  • Li C, Wu X, Yang S, et al. Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection. Diagn Pathol. 2020;15(1):131. doi: 10.1186/s13000-020-01047-2.
  • Singhi AD, Lazenby AJ, Montgomery EA. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma. Am J Surg Pathol. 2012;36(7):1030–1035. doi: 10.1097/PAS.0b013e31825033e7.
  • Ushiku T, Kunita A, Kuroda R, et al. Oxyntic gland neoplasm of the stomach: expanding the spectrum and proposal of terminology. Mod Pathol. 2020;33(2):206–216. doi: 10.1038/s41379-019-0338-1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.